These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 3159217

  • 1. Patency of saphenous veins used for aortocoronary bypass grafting: effects of platelet-derived mediators.
    Chiavarelli M, Fabi F, Chiavarelli R, Toscano M, Carpi A, Marino B.
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():311-4. PubMed ID: 3159217
    [No Abstract] [Full Text] [Related]

  • 2. Thromboxane A2 and the endoperoxides mediate canine platelet activation.
    Harris RH, Nichols R, Schmeling JW, Ramwell PW.
    Thromb Res; 1981 Sep 15; 23(6):521-32. PubMed ID: 6798707
    [No Abstract] [Full Text] [Related]

  • 3. Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation.
    Heinroth I, Block HU, Mest HJ.
    Biomed Biochim Acta; 1984 Sep 15; 43(8-9):S389-92. PubMed ID: 6440555
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [The modification of the biosynthesis and effect of thromboxane A2 and prostacyclin by trapidil (Rocornal)].
    Block HU, Heinroth I, Giessler C, Pönicke K, Mentz P, Zehl U, Rettkowski W, Dunemann A, Förster W.
    Biomed Biochim Acta; 1983 Sep 15; 42(2-3):283-99. PubMed ID: 6411078
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Inhibitory effects of the selective thromboxane receptor antagonist BM 13.177 on platelet aggregation, vasoconstriction and sudden death.
    Patscheke H, Stegmeier K, Müller-Beckmann B, Sponer G, Staiger C, Neugebauer G.
    Biomed Biochim Acta; 1984 Sep 15; 43(8-9):S312-8. PubMed ID: 6097235
    [Abstract] [Full Text] [Related]

  • 8. Effects of the prostaglandin H2/thromboxane A2 antagonist BM 13.177 on human platelets.
    Patscheke H, Stegmeier K.
    Adv Prostaglandin Thromboxane Leukot Res; 1985 Sep 15; 13():371-3. PubMed ID: 3159225
    [No Abstract] [Full Text] [Related]

  • 9. U-46619, a selective thromboxane A2-like agonist? [proceedings].
    Coleman RA, Humphrey PP, Kennedy I, Levy GP, Lumley P.
    Br J Pharmacol; 1980 Jan 15; 68(1):127P-128P. PubMed ID: 7357146
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antagonism of thromboxane A2/prostaglandin H2 by 13-azaprostanoic acid prevents platelet deposition to the de-endothelialized rabbit aorta in vivo.
    Le Breton GC, Lipowski JP, Feinberg H, Venton DL, Ho T, Wu KK.
    J Pharmacol Exp Ther; 1984 Apr 15; 229(1):80-4. PubMed ID: 6423815
    [Abstract] [Full Text] [Related]

  • 12. Stereocontrolled synthesis of 7-oxabicyclo (2.2.1) heptane prostaglandin analogs as thromboxane A2 antagonists.
    Sprague PW, Heikes JE, Harris DN, Greenberg R.
    Adv Prostaglandin Thromboxane Res; 1980 Apr 15; 6():493-6. PubMed ID: 7189952
    [No Abstract] [Full Text] [Related]

  • 13. [Thrombocyte interaction with a collagen substrate: the role of thrombocyte-synthesized prostaglandin endoperoxides and thromboxane A2].
    Mazurov AB, Leĭtin VL, Repin VS.
    Biull Eksp Biol Med; 1984 Nov 15; 98(11):563-6. PubMed ID: 6439262
    [Abstract] [Full Text] [Related]

  • 14. Effect of surgical preparation and arterialization on vasomotion of human saphenous vein.
    O'Neil GS, Chester AH, Schyns CJ, Tadjkarimi S, Borland JA, Yacoub MH.
    J Thorac Cardiovasc Surg; 1994 Mar 15; 107(3):699-706. PubMed ID: 8127099
    [Abstract] [Full Text] [Related]

  • 15. Dissociation of vasoconstrictor and platelet aggregatory activities of thromboxane by carbocyclic thromboxane A2, a stable analog of thromboxane A2.
    Lefer AM, Smith EF, Araki H, Smith JB, Aharony D, Claremon DA, Magolda RL, Nicolaou KC.
    Proc Natl Acad Sci U S A; 1980 Mar 15; 77(3):1706-10. PubMed ID: 6929517
    [Abstract] [Full Text] [Related]

  • 16. Pinane thromboxane A2: a TXA2 antagonist with antithrombotic properties.
    Aharony D, Smith JB, Smith EF, Lefer AM, Magolda RL, Nicolaou KD.
    Adv Prostaglandin Thromboxane Res; 1980 Mar 15; 6():489-92. PubMed ID: 6992538
    [No Abstract] [Full Text] [Related]

  • 17. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate.
    Lardy C, Rousselot C, Chavernac G, Depin JC, Guerrier D.
    Arzneimittelforschung; 1994 Nov 15; 44(11):1196-202. PubMed ID: 7848331
    [Abstract] [Full Text] [Related]

  • 18. The effect of naftidrofuryl on PGF2 alpha, U 46.619, 5-HT and thromboxane A2 (TXA2) induced vasoconstriction.
    Verheggen R, Schrör K.
    Biomed Biochim Acta; 1988 Nov 15; 47(10-11):S264-7. PubMed ID: 3248112
    [Abstract] [Full Text] [Related]

  • 19. Possible generation of potent vasocontracting substance from prostaglandin endoperoxide analogs, human platelets mixture.
    Shibata S, Ho WK, Ishida U.
    J Pharmacol Exp Ther; 1980 Nov 15; 215(2):357-62. PubMed ID: 7441499
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of prostanoid-mediated platelet aggregation in vivo and in vitro by 3-hydroxymethyl-dibenzo(b,f)thiepin 5,5-dioxide (L-640,035).
    Chan CC, Nathaniel DJ, Yusko PJ, Hall RA, Ford-Hutchinson AW.
    J Pharmacol Exp Ther; 1984 Apr 15; 229(1):276-82. PubMed ID: 6423813
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.